Cancer
BEMER for Cancer
Supportive care for quality of life during and after cancer treatment.
About this condition
Cancer and its treatment — surgery, chemotherapy, radiation, and immunotherapy — place enormous demands on the body's microvascular system. Healthy tissue is damaged alongside cancerous cells, circulation is compromised, and the body is left in prolonged physiological stress. BEMER Physical Vascular Therapy is not a cancer treatment. What it addresses is the systemic impact of cancer and its treatment on microcirculation — supporting oxygen delivery, nutrient supply, and cellular waste clearance at a time when the body needs it most.
How BEMER helps
Cancer-related fatigue (CRF) affects up to 90% of patients undergoing treatment and is driven in part by microcirculatory impairment — chemotherapy and radiation damage the vascular endothelium, reducing blood flow through the capillary network. By stimulating vasomotion, BEMER restores microcirculatory flow in compromised tissue, improving oxygen delivery to peripheral cells, clearing metabolic waste that contributes to fatigue, and supporting the immune system's mobility through tissue. Post-treatment, BEMER supports physical reconditioning, wound healing after surgery, and may reduce the severity of chemotherapy-induced peripheral neuropathy.
Key benefits
Important to know
Always consult your oncologist before starting BEMER therapy. BEMER is not recommended as a standalone therapy for active, untreated cancer without oncological oversight. It is generally not used on active chemotherapy infusion days. Its role is supportive — complementary to, not instead of, conventional oncology care.
Please note: Peer-reviewed research on BEMER in oncology is emerging. The strongest evidence is for cancer-related fatigue management, post-surgical healing, and peripheral neuropathy support. Studies on pulsed electromagnetic field therapy (PEMF) more broadly have demonstrated beneficial effects on quality of life, fatigue, and pain in cancer patients. BEMER's patented signal and the vasomotion research by the Institute for Microcirculation (IfM) Berlin provide a strong mechanistic foundation for these effects.